RODERICK WONG - 18 Jun 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: Director, 10%+ Owner
Signature: /s/ Martin Wilson, as attorney-in-fact for Roderick Wong
Issuer symbol: RCKT
Transactions as of: 18 Jun 2025
Transactions value $: $0
Form type: 4
Filing time: 18 Jul 2025, 16:05:40 UTC
Previous filing: 20 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
WONG RODERICK	Director, 10%+ Owner	C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY	/s/ Martin Wilson, as attorney-in-fact for Roderick Wong	18 Jul 2025	0001493280

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCKT	Common Stock	Award	$0	+30K		$0.00	30K	18 Jun 2025	Direct	F1
transaction	RCKT	Common Stock	Award	$0	+17.7K	+58.89%	$0.00	47.7K	18 Jun 2025	Direct	F2
holding	RCKT	Common Stock						18.2M	18 Jun 2025	See footnote	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026.
F2	Represents RSUs issued to the Reporting Person in lieu of director retainer fees of $50,000. The RSUs will vest in full on June 18, 2026.
F3	Represents shares held by certain investment funds managed by RTW Investments, LP (the "Adviser"). The Reporting Person serves as the Managing Partner and Chief Investment Officer of the Adviser and is a director of the Issuer and Chairman of the Issuer's Board of Directors.